ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,76
-0,64%
Dow Jones
40 211,72
0,53%
DAX
18 501,80
-0,53%
Brent Oil
83,725
-0,73%
Bitcoin
63 194,29
-2,56%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
14/02/200822h03Edgar (US Regulatory)Insmed Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:INSMInsmed Inc
13/02/200823h03Edgar (US Regulatory)Insmed Inc - Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:INSMInsmed Inc
11/02/200815h25PR Newswire (US)Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On BiologicsNASDAQ:INSMInsmed Inc
05/02/200815h55PR Newswire (US)Insmed Launches National Awareness Campaign Surrounding Follow-On BiologicsNASDAQ:INSMInsmed Inc
05/02/200815h50PR Newswire (US)Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On BiologicsNASDAQ:INSMInsmed Inc
24/01/200814h00PR Newswire (US)Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral SclerosisNASDAQ:INSMInsmed Inc
22/01/200814h00PR Newswire (US)Insmed Completes External Assessment of Myotonic Muscular Dystrophy MarketNASDAQ:INSMInsmed Inc
26/12/200722h15PR Newswire (US)Insmed to Appeal Delisting Notification From NasdaqNASDAQ:INSMInsmed Inc
18/12/200715h00PR Newswire (US)Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular DystrophyNASDAQ:INSMInsmed Inc
13/12/200713h04Edgar (US Regulatory)Insmed Inc - Current report filing (8-K)NASDAQ:INSMInsmed Inc
12/12/200722h29Edgar (US Regulatory)Insmed Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
12/12/200715h00PR Newswire (US)Insmed Awarded $2.1 Million by Muscular Dystrophy AssociationNASDAQ:INSMInsmed Inc
06/12/200722h15PR Newswire (US)Insmed Appoints Dennis M. Lanfear to Board Of DirectorsNASDAQ:INSMInsmed Inc
06/12/200715h00PR Newswire (US)Insmed to Present at the IBC 5th Annual Global Follow-On Biologics ConferenceNASDAQ:INSMInsmed Inc
03/12/200715h15PR Newswire (US)Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate CommunicationsNASDAQ:INSMInsmed Inc
15/11/200721h21Edgar (US Regulatory)Insmed Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
09/11/200722h08Edgar (US Regulatory)Insmed Inc - Quarterly Report (10-Q)NASDAQ:INSMInsmed Inc
02/08/200715h15Business WireInsmed Reports Financial Results for Second Quarter and First Half of 2007NASDAQ:INSMInsmed Inc
25/07/200715h15Business WireInsmed Announces Second Quarter and First Half Earnings Release Date and Conference CallNASDAQ:INSMInsmed Inc
09/07/200715h00Business WireInsmed Inc. to Present at C.E. Unterberg, Towbin Growth ConferenceNASDAQ:INSMInsmed Inc
26/06/200715h15Business WireInsmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature InfantsNASDAQ:INSMInsmed Inc
25/06/200715h00Business WireExperienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on BiologicsNASDAQ:INSMInsmed Inc
19/06/200722h15Business WireInsmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid PriceNASDAQ:INSMInsmed Inc
10/05/200715h00Business WireInsmed Incorporated Reports Financial Results for First Quarter Ended March 31, 2007NASDAQ:INSMInsmed Inc
08/05/200702h00Business WireInsmed Announces First Quarter Earnings Release Date and Conference CallNASDAQ:INSMInsmed Inc
04/05/200715h05Business WireInsmed Raises Approximately $18.2 Million in Registered Direct OfferingNASDAQ:INSMInsmed Inc
03/05/200715h15Business WireInsmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical StudyNASDAQ:INSMInsmed Inc
02/05/200715h00Business WireInsmed CEO Geoffrey Allan Testifies at Energy and Commerce Committee HearingNASDAQ:INSMInsmed Inc
30/04/200715h00Business WireInsmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical StudyNASDAQ:INSMInsmed Inc
25/04/200715h01Business WireInsmed Inc. Releases Investor Fact Sheet with Updates on Drug Development ProgressNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
RNO
Renault
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
EU
CS
Axa
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
NYSE
MRK
Merck
EU
PX1
CAC 40
SPI
SP500
S&P 500
EU
HO
Thales
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés